TGA seeks inputs
November 25, 2013
The Therapeutic Goods
Administration (TGA) is seeking
submissions from interested
parties on advisory statements for
chloramphenicol, propamidine,
dibromopropamidine and
sulfacetamide, when included in
non-prescription medicines for
ophthalmic use.
The closing date for submissions
is Jan 10, 2014.
In addition, input is sought
regarding draft composition
guidelines for astaxanthin esters
from haematococcus pluvialis,
DHA/EPA rich Schizochytrium algal
oil and calcium L-threonate.
For details regarding these and
other TGA matters, CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 25 Nov 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Nov 13